Logo
x

Search

Subscribe Now

Bayer

Bayer Submits NDA of Elinzanetant, Seeking Approval in the US for Vasomotor Symptoms Treatment

Bayer Submits NDA of Elinzanetant, Seeking Approval in the US for Vasomotor Symptoms Treatment

  • August 2, 2024
Bayer Provides Update on P-III (ARANOTE) Study of Darolutamide to Treat Metastatic Hormone-Sensitive Prostate Cancer

Bayer Provides Update on P-III (ARANOTE) Study of Darolutamide to Treat Metastatic Hormone-Sensitive Prostate Cancer

  • July 17, 2024
Bayer and Evotec Join Forces to Develop Treatment for Cardiovascular Diseases

Bayer and Evotec Join Forces to Develop Treatment for Cardiovascular Diseases

  • April 30, 2024
Bayer Collaborates with Google Cloud to Develop AI-Based Solutions for Radiologists

Bayer Collaborates with Google Cloud to Develop AI-Based Solutions for Radiologists

  • April 10, 2024
Bayer and Thermo Fisher Scientific Partner to Develop NGS-Based Companion Diagnostic Assays (CDx)

Bayer and Thermo Fisher Scientific Partner to Develop NGS-Based Companion Diagnostic Assays (CDx)

  • March 21, 2024
Bayer Reports Data from the P-III (OASIS 3) Trial of Elinzanetant for Treating Vasomotor Symptoms in Postmenopausal Women

Bayer Reports Data from the P-III (OASIS 3) Trial of Elinzanetant for Treating Vasomotor Symptoms in Postmenopausal Women

  • March 20, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.